| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Reviews |
1Immune Disease Institute and 2Department of Pathology, Harvard Medical School, Boston, Massachusetts; and 3Inserm Unit 698, Bichat Hospital, Paris, France, and 4University of Münster, Department of Dermatology, Münster, Germany
* To whom correspondence should be addressed. E-mail: wagner{at}idi.harvard.edu.
| Abstract |
|---|
Solid tumors generate a prothrombotic environment capable of platelet activation. Recent findings indicate that the activated platelets are crucial regulators of tumor vascular homeostasis in that they prevent tumor hemorrhage. Surprisingly, this effect is independent of platelets' capacity to form thrombi and instead relies on the secretion of their granule content. Thus, targeting platelet secretory activities may represent a new approach to specifically destabilize tumor vasculature. [Cancer Res 2009;69(14):5623–6]
This article has been cited by other articles:
![]() |
G. C. Prendergast Platelets in Maintaining Tumor Vasculature and Applying Evolution Theory in Cancer Cancer Reviews Online Content, August 1, 2009; 2009(8): 15 - 15. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |